Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

Completed

Conditions studied: Breast Cancer, Lung Cancer, Colorectal Cancer

In brief

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best chemotherapy choices for their patients. The investigators will conduct focus groups with cancer patients who have received chemotherapy treatment at MSK in order to understand cancer patients' thoughts about IBM Watson Oncology.

Key facts

Study ID

NCT02565017

Run by

Memorial Sloan Kettering Cancer Center

People needed

70

Starts

2015-09-15

Expected to finish

2020-06-22

Last updated by the study team

2020-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• MSKCC patient 18 years or older
• Breast, lung, or colorectal cancer MSK patient as per EMR or clinician judgment having either:
• Chemotherapeutic adjuvant or neoadjuvant treatment with the first chemo visit occurring within the past 8 months and primary treatment (i.e., surgery), occurring within the past 6 months)at MSK
• OR chemotherapeutic treatment for metastatic disease with the first chemo visit occurring within the past 8 months at MSK
• OR chemotherapeutic treatment through an on-going MSK clinical trial as per clinician
• Residing in New York metro-area

You may not qualify if…

• Non-English speakers because we do not have the resources to conduct and translate the focus groups into other languages
• Patients who are not or will not receive their cancer care at MSKCC.
• Patient unwilling or unable to provide informed consent

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.